Allison Jarrett
Medical · Merrillville, INNPI 1841882834
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,007 of the $10,270 with a category attached, or 78.0%. 60 manufacturers reported payments, led by Novartis at 30.2% of the total. 2025 is the largest year on record at $3,413, 8.3 times the $412 reported in 2021. Among medical clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 382 payments — averaging $26.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$3K
- AstraZeneca$683
- Merck$551
- E.r. Squibb & Sons, L.L.C.$453
- Johnson & Johnson$396
- Daiichi Sankyo Inc.$331
- plus $5K from 54 others
What the payments were for
- Food & beverage$8,00778%
- Education$991%
- Other$2,16421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$10,270 in reported general payments places this provider in the 90th percentile of 273 medical providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lenalidomide | 27 | $348,096 |
| PomalystPomalidomide | 16 | $307,461 |
| TasignaNilotinib Hcl | 13 | $242,474 |
| ImbruvicaIbrutinib | 12 | $196,643 |
| TagrissoOsimertinib Mesylate | 12 | $190,740 |
| EliquisApixaban | 29 | $25,647 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 70 | $1,865 |
| Fentanyl | 11 | $1,506 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $713 |
| Warfarin Sodium | 119 | $608 |
| Anastrozole | 40 | $563 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 20 | $471 |
| Levothyroxine Sodium | 18 | $374 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $348 |
| Letrozole | 16 | $221 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| E.r. Squibb & Sons, L.L.C.Pomalyst | $453 | $307,46116 claims |
| NovartisTasigna | $3,097 | $242,47413 claims |
| AstraZenecaTagrisso | $683 | $190,74012 claims |
| PfizerEliquis | $329 | $25,64729 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 273 medical providers in Indiana.
Other medical in Merrillville
- Nicole PetersonMerrillville$6K
- Meggie BeckleyIndianapolis$125K
- Jennifer ConnerIndianapolis$98K
- Brandon BoydCarmel$46K
- Karey DavisNew Castle$45K
- Sheryl NewCarmel$39K
- Lindsey GradyValparaiso$39K
- Jennifer IrwinIndianapolis$34K
- Dennae DaltonZionsville$33K
- Jenifer FortneyFort Wayne$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.